Abstract:
:Bortezomib is a novel anti-cancer agent which has shown promising activity in non-small lung cancer (NSCLC) patients. However, only a subset of patients respond to this treatment. We show that NSCLC cell lines are differentially sensitive to bortezomib, IC50 values ranging from 5 to 83 nM. The apoptosis-inducing potential of bortezomib in NSCLC cells was found to be dependent not only on the apoptotic phenotype but also on the proteasomal phenotype of individual cell lines. Upon effective proteasome inhibition, H460 cells were more susceptible to apoptosis induction by bortezomib than SW1573 cells, indicating a different apoptotic phenotype. However, exposure to a low dose of bortezomib did only result in SW1573 cells, and not in H460 cells, in inhibition of proteasome activity and subsequent apoptosis. This suggests a different proteasomal phenotype as well. Additionally, overexpression of anti-apoptotic protein Bcl-2 in H460 cells did not affect the proteasomal phenotype of H460 cells but did result in decreased bortezomib-induced apoptosis. In conclusion, successful proteasome-inhibitor based treatment strategies in NSCLC face the challenge of having to overcome apoptosis resistance as well as proteasomal resistance of individual lung cancer cells. Further studies in NSCLC are warranted to elucidate underlying mechanisms.
journal_name
Mol Cancerjournal_title
Molecular cancerauthors
Voortman J,Checińska A,Giaccone Gdoi
10.1186/1476-4598-6-73subject
Has Abstractpub_date
2007-11-17 00:00:00pages
73issn
1476-4598pii
1476-4598-6-73journal_volume
6pub_type
杂志文章相关文献
Molecular Cancer文献大全abstract:BACKGROUND:Transforming Growth Factor beta (TGF-beta) plays an important role in tumor invasion and metastasis. We set out to investigate the possible clinical utility of TGF-beta antagonists in a human metastatic basal-like breast cancer model. We examined the effects of two types of the TGF-beta pathway antagonists (...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-9-122
更新日期:2010-05-26 00:00:00
abstract:BACKGROUND:Peroxisome proliferator-activated receptor gamma (PPARgamma) is a member of the nuclear hormone receptor superfamily and is highly expressed in many human tumors including breast cancer. PPARgamma has been identified as a potential target for breast cancer therapy based on the fact that its activation by syn...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-7-90
更新日期:2008-12-05 00:00:00
abstract:BACKGROUND:Though esophageal cancer is three to four times more common among males than females worldwide, this type of cancer still ranks in the top incidence among women, even more than the female specific cancer types. The occurrence is currently attributed to extrinsic factors, including tobacco use and alcohol con...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-019-0949-7
更新日期:2019-02-08 00:00:00
abstract:BACKGROUND:ADAMTS-1 (a disintegrin and metalloprotease with thrombospondin motifs) is a member of the ADAMTS family of metalloproteases. Here, we investigated mRNA and protein levels of ADAMTS-1 in normal and neoplastic tissues using qPCR, immunohistochemistry and immunoblot analyses, and we addressed the role of ADAMT...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-12-2
更新日期:2013-01-05 00:00:00
abstract::Inflammasomes are large intracellular multi-protein signalling complexes that are formed in the cytosolic compartment as an inflammatory immune response to endogenous danger signals. The formation of the inflammasome enables activation of an inflammatory protease caspase-1, pyroptosis initiation with the subsequent cl...
journal_title:Molecular cancer
pub_type: 杂志文章,评审
doi:10.1186/s12943-018-0900-3
更新日期:2018-11-17 00:00:00
abstract:BACKGROUND:In our previous studies, we have demonstrated that insulin-like growth factor binding protein-related protein1 (IGFBP-rP1) played its potential tumor suppressor role in colon cancer cells through apoptosis and senescence induction. In this study, we will further uncover the role of IGFBP-rP1 in colon cancer ...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-9-281
更新日期:2010-10-26 00:00:00
abstract:BACKGROUND:Cancer is the result of a multistep process of genomic alterations, including mutations in key regulatory proteins that result in loss of balanced gene expression and subsequent malignant transformation. Throughout the various stages of colorectal carcinoma (CRC), complex genetic alterations occur, of which ...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-13-21
更新日期:2014-02-04 00:00:00
abstract:BACKGROUND:Emerging studies suggest that long non-coding RNAs (lncRNAs) play crucial roles in colorectal cancer (CRC). Here, we report a lncRNA, SATB2-AS1, which is specifically expressed in colorectal tissue and is significantly reduced in CRC. We systematically elucidated its functions and possible molecular mechanis...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-019-1063-6
更新日期:2019-09-06 00:00:00
abstract:BACKGROUND:The tumor cell lysate-pulsed, dendritic cell (DC)-based cancer vaccine approaches are being actively evaluated for application to cancer immunotherapy, hopefully at a personalized medicine base. There is apparently an emerging technical problem however, the lack of highly efficacious potency in activation of...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-015-0435-9
更新日期:2015-09-24 00:00:00
abstract:BACKGROUND:Medulloblastoma is the most common type of malignant brain tumor that afflicts children. Although recent advances in chemotherapy and radiation have improved outcomes, high-risk patients do poorly with significant morbidity. METHODS:To identify new molecular targets, we performed an integrated genomic analy...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-13-72
更新日期:2014-03-24 00:00:00
abstract:BACKGROUND:Fusion of the MOZ and TIF2 genes by an inv (8) (p11q13) translocation has been identified in patients with acute mixed-lineage leukemia. Characterization of the molecular structure of the MOZ-TIF2 fusion protein suggested that the fusion protein would effect on nuclear receptor signaling. RESULTS:A series o...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-6-51
更新日期:2007-08-13 00:00:00
abstract:BACKGROUND:Targeted therapies have improved therapeutic options of treating renal cell carcinoma (RCC). However, drug response is temporary due to resistance development. METHODS:Functional and molecular changes in RCC Caki-1 cells, after acquired resistance to the mammalian target of rapamycin (mTOR)-inhibitor everol...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-13-152
更新日期:2014-06-16 00:00:00
abstract:BACKGROUND:Increasing evidence supports the role of small nucleolar RNAs (snoRNAs) and long non-coding RNAs (lncRNAs) as master gene regulators at the epigenetic modification level. However, the underlying mechanism of these functional ncRNAs in colorectal cancer (CRC) has not been well investigated. METHODS:The dysre...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-020-01201-w
更新日期:2020-05-22 00:00:00
abstract:BACKGROUND:The epigenetic regulation of immune response has been demonstrated in recent studies. Nonetheless, potential roles of RNA N6-methyladenosine (m6A) modification in tumor microenvironment (TME) cell infiltration remain unknown. METHODS:We comprehensively evaluated the m6A modification patterns of 1938 gastric...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-020-01170-0
更新日期:2020-03-12 00:00:00
abstract:BACKGROUND:Perifosine, an alkylphospholipid tested in phase II clinical trials, modulates the extrinsic apoptotic pathway and cooperates with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to augment apoptosis. The current study focuses on revealing the mechanisms by which perifosine enhances TRAIL-ind...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-9-315
更新日期:2010-12-20 00:00:00
abstract::Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignant diseases worldwide. It is refractory to conventional treatments, and consequently has a documented 5-year survival rate as low as 7%. Increasing evidence indicates that activated pancreatic stellate cells (PSCs), one of the stromal components ...
journal_title:Molecular cancer
pub_type: 杂志文章,评审
doi:10.1186/s12943-018-0815-z
更新日期:2018-02-19 00:00:00
abstract:BACKGROUND:Although the prognosis of gastric cancer patients have a favorable progression, there are some patients with unusual patterns of locoregional and systemic recurrence. Therefore, a better understanding of early molecular events of the disease is needed. Current evidences demonstrate that long noncoding RNAs (...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-017-0588-9
更新日期:2017-02-16 00:00:00
abstract:BACKGROUND:Recent studies indicate that circular RNA (circRNA) plays a pivotal role in cancer progression. Here, we sought to investigate its role in breast cancer. METHODS:CircANKS1B (a circRNA originated from exons 5 to 8 of the ANKS1B gene, hsa_circ_0007294) was identified by RNA-sequencing and validated by qRT-PCR...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-018-0914-x
更新日期:2018-11-19 00:00:00
abstract:BACKGROUND:Survivin is a dual function protein. It inhibits the apoptosis of cells by inhibiting caspases, and also promotes cell growth by stabilizing microtubules during mitosis. Over-expression of survivin has been demonstrated to induce drug-resistance to various chemo-therapeutic agents such as cisplatin (DNA dama...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-8-43
更新日期:2009-07-03 00:00:00
abstract::Although solid tumors comprise malignant cells, they also contain many different non-malignant cell types in their micro-environment. The cellular components of the tumor stroma consist of immune and endothelial cells combined with a heterogeneous population of stromal cells which include cancer-associated fibroblasts...
journal_title:Molecular cancer
pub_type: 杂志文章,评审
doi:10.1186/s12943-019-0960-z
更新日期:2019-03-30 00:00:00
abstract:BACKGROUND:Although gemcitabine-based chemotherapy has been established as a core multimodal therapy for non-small cell lung cancer (NSCLC) treatment, its clinical efficacy remains limited by the development of acquired resistance following tumor metastasis and relapse. In this study, we investigated how gemcitabine-re...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-017-0694-8
更新日期:2017-07-25 00:00:00
abstract:BACKGROUND:Head and neck squamous cell carcinoma (HNSCC) is a highly lethal cancer that contains cellular and functional heterogeneity. Previously, we enriched a subpopulation of highly tumorigenic head and neck cancer initiating cells (HN-CICs) from HNSCC. However, the molecular mechanisms by which to govern the chara...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-9-283
更新日期:2010-10-27 00:00:00
abstract:BACKGROUND:Akt/PKB is a serine/threonine kinase that has attracted much attention because of its central role in regulating cell proliferation, survival, motility and angiogenesis. Activation of Akt in breast cancer portends aggressive tumour behaviour, resistance to hormone-, chemo-, and radiotherapy-induced apoptosis...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-8-58
更新日期:2009-08-03 00:00:00
abstract::The HER4 intracellular domain (4ICD) is a potent estrogen receptor (ERalpha) coactivator with activities in breast cancer and the developing mammary gland that appear to overlap with progesterone receptor (PgR). In fact, 4ICD has recently emerged as an important regulator and predictor of tamoxifen response, a role pr...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-9-150
更新日期:2010-06-15 00:00:00
abstract:BACKGROUND:Neuroblastoma is responsible for 15% of all childhood cancer deaths. Despite advances in treatment and disease management, the overall 5-year survival rates remain poor in high-risk disease (25-40%). MiR-497 was previously identified by our laboratory as a member of a miRNA expression signature, predictive o...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-12-23
更新日期:2013-03-26 00:00:00
abstract:BACKGROUND:Chromosomal aberrations of BCL11A at 2p16.1 have been reported in a variety of B-cell malignancies and its deficiency in mice leads to a profound block in B-cell development. RESULTS:Alternative pre-mRNA splicing of BCL11A produces multiple isoforms sharing a common N-terminus. The most abundant isoform we ...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-5-18
更新日期:2006-05-16 00:00:00
abstract:BACKGROUND:microRNAs (miRNAs) play both oncogenic and oncostatic roles in leukemia. However, the molecular details underlying miRNA-mediated regulation of their target genes in pediatric B- and T-cell acute lymphoblastic leukemias (ALLs) remain unclear. The present study investigated the relationship between miR-2909 a...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/1476-4598-13-175
更新日期:2014-07-18 00:00:00
abstract:BACKGROUND:The Sonic hedgehog (Shh) signaling pathway plays an important role in cerebellar development, and mutations leading to hyperactive Shh signaling have been associated with certain forms of medulloblastoma, a common form of pediatric brain cancer. While the fundamentals of this pathway are known, the molecular...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-015-0430-1
更新日期:2015-08-19 00:00:00
abstract:BACKGROUND:As an important means of communication, exosomes play an important role in the development of hepatocellular carcinoma (HCC). METHODS:Bioinformatics analysis, dual-luciferase reporter assays, methylation-specific quantitative PCR, and ChIP-PCR analysis were used to gain insight into the underlying mechanism...
journal_title:Molecular cancer
pub_type: 杂志文章
doi:10.1186/s12943-019-1075-2
更新日期:2019-10-27 00:00:00
abstract::The correlation between epigenetic aberrations and disease underscores the importance of epigenetic mechanisms. Here, we review recent findings regarding chromatin modifications and their relevance to cancer. ...
journal_title:Molecular cancer
pub_type: 杂志文章,评审
doi:10.1186/1476-4598-5-60
更新日期:2006-11-08 00:00:00